Patient
SITE008-0199
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE008 (KOR) (Dr. Kim)
consented 2026-04-26
Adverse events
2
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-08-23
Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-02-16 (study day 104); relationship: not assessed
severe
serious
assessed
2026-06-27
Grade 4 Alopecia — outcome: RECOVERED/RESOLVED; onset 2022-12-21 (study day 47); relationship: not assessed; serious criteria: life-threatening
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.